AC

Aisling Capital Portfolio holdings

AUM $45.3M
This Quarter Return
+14.29%
1 Year Return
-15.24%
3 Year Return
+386.13%
5 Year Return
+1,047.82%
10 Year Return
AUM
$609M
AUM Growth
+$609M
Cap. Flow
-$42.1M
Cap. Flow %
-6.91%
Top 10 Hldgs %
99.31%
Holding
17
New
1
Increased
Reduced
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
$386M 63.39% 4,188,920
AIMT
2
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$74.1M 12.18% 2,990,000
VRAY
3
DELISTED
ViewRay, Inc.
VRAY
$43.1M 7.08% 7,480,887
ESPR icon
4
Esperion Therapeutics
ESPR
$448M
$42M 6.89% 837,125
ASXC
5
DELISTED
Asensus Surgical, Inc.
ASXC
$14.8M 2.43% 10,335,819
ADMA icon
6
ADMA Biologics
ADMA
$4.12B
$11.1M 1.83% 3,608,171
ENTL
7
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$9.76M 1.6% +528,655 New +$9.76M
CDTX icon
8
Cidara Therapeutics
CDTX
$1.66B
$8.27M 1.36% 1,021,148
AGRX
9
DELISTED
Agile Therapeutics, Inc
AGRX
$8.05M 1.32% 1,804,933
SYRS
10
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$7.49M 1.23% 508,565
CMRX
11
DELISTED
Chimerix, Inc.
CMRX
$2.48M 0.41% 472,943
PTX
12
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$662K 0.11% 210,000
TTOO
13
DELISTED
T2 Biosystems, Inc
TTOO
-1,523,499 Closed -$4.89M
ARAV
14
DELISTED
Aravive, Inc. Common Stock
ARAV
-2,024,465 Closed -$35.3M
PRTK
15
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-482,680 Closed -$11.6M
ZLTQ
16
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$0 ﹤0.01% 11,985